Integrating circulating tumor cell assays into the management of breast cancer

Current Treatment Options in Oncology

Volumn 8, Issue 1, 2007, Pages 89-95

  Dawood, Shaheenah ^a   Cristofanilli, Massimo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; TUMOR MARKER;

BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CELL ASSAY; CELL LEVEL; CELL MIGRATION; CIRCULATING TUMOR CELL; DOSE RESPONSE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROGNOSIS; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR CELL; BLOOD; BREAST TUMOR; CLINICAL TRIAL; DISEASE COURSE; FEMALE; METABOLISM; METASTASIS; METHODOLOGY; PATHOLOGY; TUMOR EMBOLISM;

BREAST NEOPLASMS; CLINICAL TRIALS; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; NEOPLASM STAGING; RESEARCH DESIGN; TUMOR MARKERS, BIOLOGICAL;

EID: 36048931702     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-007-0018-0     Document Type: Review

References (27)

1. Smigal C, Jemal A, Ward E, et al. (2006) Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin. 56(3):168-183
2. Yamamoto N, Watanebe T, Katsumata N, et al. (1998) Construction and validation of a practical prognostic index for patients with metastatic breast cancer. J Clin Oncol 16:2401-2408
3. Jemal A, Siegal R, Ward E et al. (2006) Cancer Statistics, 2006. CA Cancer J Clin. 56(2):106-130
4. Clark SE, Sener SF, Wilkens W, et al. (1997) Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 285:1182-1186
5. Braun S, Pantel K, Muller P, et al. (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 342:525-533
6. Lacroix J, Doebritz MK (2001) Technical aspects of minimal residual disease detection in carcinoma patients. Semin Surg Oncol 20:252-264
7. Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448-456
8. Chang YS, et al. (2000) Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97:14608-14613
9. Meng S, Tripathy D, Frenkel EP, et al. (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10:8152-8162
10. Mehes G, et al. (2001) Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159:17-20
11. Bossolasco P, Ricci C, Farina G, et al. (2002).Detection of micrometastatic cells in breast cancer by RT-PCR for the mammaglobin gene. Cancer Detec Prev 26:60-63
12. Racila E, Euhus D, Weiss AJ, et al. (2002) Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 8:1085-1091
13. Pachmann K, HiessP, Demel U, et al. (2001) Detection and quantification of small numbers of circulating tumor cells in peripheral blood using laser scanning cytometer (LSC). Clin Chem Lab Med 39:811-817
14. Kagan M, Howard D, Bendele T, et al. (2002) A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 25:104-110
15. Terstappen LW, Rao C, Gross S, et al. (2000) Peripheral blood tumor cell load relects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol 17:573-578
16. Cristofanilli M, Budd GT, Ellis M, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-91 (A pivotal multi institutional study that prospectively evaluated the prognostic and predictive role of CTCs in 177 patients with MBC)
17. Hayes DF, Cristofanilli M, Budd GT, et al. (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12(14):4218-4224 (An important study that looked at the prognostic and predictive significance of changing levels of CTCs at various intervals in the course of treatment in patients with MBC)
18. Budd GT, Cristofanilli M, Eillis MJ, et al. (2006) Circulating tumor cells versus imaging-predicting overall survival in Metastatic Breast Cancer. Clin Cancer Res 12(21):6403-6409 (An important study that compared the prognostic and predictive power of CTCs to radiologic imaging in patients with MBC)
19. Hayes DF, Walker TM, Singh B, et al. (2002) Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 21:1111-1117
20. Mavroudis D, Apostolaki S, Perraki M, et al. (2006) Detection of HER2 and CK-19 mRNA-positive circulating tumor cells (CTCs) in the peripheral blood of patients with early stage breast cancer (abstract). Proc Am Assoc Cancer Res 47:5148
21. Budd GT, Cristofanilli M, Ellis MJ, et al. (2005) Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC). Proc Annu Meet Am Soc Clin Oncol 24:A503
22. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet, 2005, 365:1687-1717
23. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet, 1998, 352:930-942
24. Pachmann K, Camara O, Kavallaris A, et al. (2005) Quantification of the response of circulating epithelial cells to neoadjuvant treatment for breast cancer: A new tool for therapy monitoring. Breast Cancer Res 7:975-979
25. Xenidis N, Perraki M, Kafousi M, et al. (2006) Predictive and prognostic value of peripheral blood cyotokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Onc 24:3756-3762
26. Green FL, Page DI, Flemming ID, et al. (2002). AJCC Cancer Staging Manual. (ed 6). New York, NY, Springer
27. Reed W, Bohler PJ, Sandstad B, et al. (2004) Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Breast J 10:174-180